Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours). Elaine Sarkin Jaffe

Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)


Pathology.and.Genetics.Tumours.of.Haematopoietic.and.Lymphoid.Tissues.pdf
ISBN: 9283224116,9789283224112 | 352 pages | 9 Mb


Download Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)



Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours) Elaine Sarkin Jaffe
Publisher:




HTLV-I and STLV-I are Cell line DNA was diluted in genomic DNA from healthy individuals. This authoritative, concise reference book covers the entire range of leukaemias and lymphomas. Harris NL JE, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW, (Eds): Pathology and genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001. EKLF has surprisingly been associated with tumors such as cancer in the endometrial epithelial cells, and is increased by treatment with tamoxifen or oestrogen [27]. EKLF mRNA expression is correlated with expression .. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue is the third volume in the new WHO series on histological and genetic typing of human tumors. It provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. It did not show sufficient homology to be classified as primate T-cell lymphotropic virus (PTLV) type I, II or III and was thus considered to be a species representative of a hitherto unknown putative PTLV-IV virus group [12]. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. In: Jaffe ES, Harris NL, Stein H, et al., eds.: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Lee Harris N, Stein H, Vardiman JW: World Health Organization classification of tumors: Pathology and genetics of tumors of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours, 3, pp 77-80. The recent and ongoing rapid WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue is the third volume in the new WHO series on histological and genetic typing of human tumors.